All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia

Wei J. et al, (2024), Journal of Infection

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity

Hamid MHBA. et al, (2024), Nature Immunology

Lung Ultrasound Reproducibly Outperforms Computed Tomography in the Detection of Extravascular Lung Water in Patients Undergoing Haemodialysis

Corcoran JP. et al, (2024), Diagnostics, 14, 589 - 589

Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD.

Price E. et al, (2024), ERJ open research, 10, 10 - 2024

Pleural Diseases in Connective Tissue Diseases.

Guo H. et al, (2024), Seminars in respiratory and critical care medicine

Reply to: Insights on the ERS/ESTS statement on the management of pleural infection in adults.

Bedawi EO. and Rahman NM., (2024), The European respiratory journal, 63

The lung is not a balloon: the self-sealing property of the lung.

Chopra A. et al, (2024), The Lancet. Respiratory medicine, 12, 190 - 192

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Standing JF. et al, (2024), Nature Communications, 15

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

Elneima O. et al, (2024), International Journal of Epidemiology, 53

Man versus Machine in Pleural Diagnostics: Does Artificial Intelligence Provide the Solution?

Addala DN. and Rahman NM., (2024), Annals of the American Thoracic Society, 21, 202 - 203

Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial

Png ME. et al, (2024), British Journal of General Practice, BJGP.2023.0444 - BJGP.2023.0444

Evaluation of the RAPID score as a predictor of postoperative morbidity and mortality in patients undergoing pulmonary decortication for stage III pleural empyema

Carneiro DC. et al, (2024), Clinics, 79, 100356 - 100356

Malignant pleural effusion: current understanding and therapeutic approach.

Gonnelli F. et al, (2024), Respiratory research, 25

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

Taquet M. et al, (2023), Brain Communications, 6

Diagnosis and management of pleural infection.

Elsheikh A. et al, (2023), Breathe (Sheffield, England), 19

PET-CT guided versus CT-guided biopsy in suspected malignant pleural thickening; a randomised trial.

De Fonseka D. et al, (2023), The European respiratory journal

The European Respiratory Society led training programme improves self-reported competency and increases the use of thoracic ultrasound.

Pietersen PI. et al, (2023), Breathe (Sheffield, England), 19

Comparison of video assisted thoracoscopic surgery and thoracotomy for treatment of pleural infection stage II and III: a literature review.

Steen K. et al, (2023), J Thorac Dis, 15, 6323 - 6332

Investigation of Simulated Adherence in Long-Term Buprenorphine/Naloxone Treatment Patients.

Rahman N. et al, (2023), Substance use & misuse, 1 - 5

Long COVID research: an update from the PHOSP-COVID Scientific Summit

Brightling CE. et al, (2023), The Lancet Respiratory Medicine, 11, e93 - e94

Cookies on this website

All Publications